ADA 2025
20 - 23 June 2025
Efficacy and Safety of Semaglutide 7.2 mg in Obesity and Type 2 Diabetes: The STEP UP T2D Trial
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.